Financials
- Fiscal year
- 2026
- Total assets
- €109,726
- Profit
- €50,993
- Solvency
- 54.8%
Total assets▲ 50.5%
Net result
20212026
EAS-MED
ActiveSummary
EAS-MED has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €60,100 and a net result of €50,993. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 39% of 177 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Activity
Specialist medical practice
NACE 86220
1 site
Size
€109,726total assets 2026
- Equity
- €60,100
- Profit
- €50,993
Turnover not published (abridged schema)
Structure
Accounts 41 d early0 of 1 deed read
Why 95- Founded in 2019+ Sector Human health activities (NACE 86)+ Figures for FY 2026 (filed 20-09-2026)+ Size: total assets €109,726Show the evidence
Checked score
Score 2026
95
/ 100
Excellent
Probability in this band: under 0.55%
Better than 58% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2025
Strong
Solvency
80+43
equity 54.8% of total assets
Liquidity
34+26
short-term debt 45.2% · cash 4.8%
Profitability
100+17
return on assets 46.5%
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.1%
12-2024: 0.1%▼ -0.8% vs 11-2024
01-2025: 0.1%▼ -2.4% vs 12-2024
02-2025: 0.1%▼ -1.7% vs 01-2025
03-2025: 0.1%● 0.0% vs 02-2025
04-2025: 0.1%▼ -3.4% vs 03-2025
05-2025: 0.1%● 0.0% vs 04-2025
06-2025: 0.1%▲ +23.5% vs 05-2025
07-2025: 0.2%▲ +12.0% vs 06-2025
08-2025: 0.1%▼ -8.2% vs 07-2025
09-2025: 0.1%▲ +1.4% vs 08-2025
10-2025: 0.2%▲ +20.3% vs 09-2025
11-2025: 0.4%▲ +101% vs 10-2025
12-2025: 0.4%● 0.0% vs 11-2025
01-2026: 0.4%● 0.0% vs 12-2025
02-2026: 0.4%● 0.0% vs 01-2026
03-2026: 0.3%▼ -3.9% vs 02-2026
04-2026: 0.3%▼ -1.5% vs 03-2026
05-2026: 0.3%● 0.0% vs 04-2026
06-2026: 0.4%▲ +16.5% vs 05-2026
07-2026: 0.4%▲ +3.5% vs 06-2026highest value
08-2026: 0.4%▼ -3.4% vs 07-2026
09-2026: 0.4%▼ -4.1% vs 08-2026
10-2026: 0.1%▼ -83.4% vs 09-2026lowest value
- Sector Human health activities (NACE 86) lowers the probability
- Figures for FY 2026 (filed 20-09-2026) lowers the probability
- Size: total assets €109,726 lowers the probability for this profile
- Founded in 2019 raises the probability for this profile
Credit up to €5,000 at 30 days acceptable
Liquidity short (current ratio 0.71 against 0.16 in 2025; short-term debt: 45.2% and cash: 4.8% of total assets), and 45.2% of the assets are financed with debt.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 44%, liquidity 7%, profitability 80%, growth against the median 99%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Growing equity
Reported equity is higher than in 2024 and did not fall compared with 2025. These amounts do not establish the cause of the change.
NBB · annual accounts 2026Equity per financial year
212223242526
2021 to 2026 · latest year €60,100
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2026 was due by 31-10-2026 and was filed on 20-09-2026, 41 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2026
41 d early
2025
3 d early
2024
65 d early
2023
34 d early
2022
3 d late
2021
on the day
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 23 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2027 and is due by 31-10-2027. Nothing is late today. Usually files around 27 September (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven monthsPosition in the running window
03-10-2026 today31-03-2027 close31-10-2027 deadline
- Annual accounts filedfiscal year 2026 · micro…
- Highest result since 2021net €50,993 ▲494%
- Annual accounts filedfiscal year 2025 · micro…
Key points
By topic
Timeline
- Events
- 9
- Since
- 2021
- Next accounts
- by 31-10-2027
- 20-09-2026Annual accounts filed
- 31-03-2026Highest result since 2021
- 28-10-2025Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Specialist medical practiceNACE 86220
- Founded
- 09-12-2019
- Year ends
- 31-03
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.